List prices don't reflect the rebates negotiated between drug manufacturers and payers, but they are often used to determine Medicare Part D cost sharing — meaning as prices go up, patients pay more out of pocket.More than 8 million Americans regularly take blood thinners. Until 2010, the standard of care was warfarin, which was cheap but carried the risk of heavy bleeding.
Those list prices have increased in tandem over time, and both are now more than $500 for a month's supply.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: